INTRODUCTION
In common with most other non-excitable cells hepatocytes possess receptor-operated Ca2+ channels in the plasma membrane. These channels are activated by a variety of agonists including vasopressin, angiotensin II, adrenalin and epidermal growth factor (EGF) (reviewed in Barritt and Hughes, 1991) . The putative Ca2+ channels appear to be non-selective for bivalent cations since there is evidence that they admit Mn2 , some other bivalent cations (reviewed in Barritt and Hughes, 1991) and Na+ (Lidofsky et al., 1993) . Agonist-stimulated bivalent cation inflow is mimicked by the incubation of hepatocytes with thapsigargin or 2,5-di-tert-butylhydroquinone (DBHQ) (Kass et al., 1989 (Kass et al., , 1990 Hansen et al., 1991; Llopis et al., 1992; Glennon et al., 1992; Strazzari and Hughes, 1993) . These agents induce the release of Ca2+ from intracellular Ca2+ stores without increasing the concentration of inositol 1,4,5-trisphosphate (InsP3) (Moore et al., 1987; Takemura et al., 1989) . Agonist-stimulated bivalent cation inflow in hepatocytes also exhibits requirements for a prior increase in InsP3 Berven et al., 1994) and a slowly ADP-ribosylated pertussis toxin-sensitive trimeric GTP-binding protein (trimeric G-protein) (Hughes et al., 1987; Butta et al., 1993; Berven et al., 1994) . The 'capacitative' or 'store-operated' Ca2+ inflow hypothesis (Putney, 1986 ) is currently considered to be the best hypothesis for the mechanism of activation of the hepatocyte receptor-operated Ca2+ channels as it is consistent with all the available data (Glennon et al., 1992) . This hypothesis states that the emptying of InsP3-sensitive Ca2+ stores (induced by the agonist) activates the putative Ca2+ channels. However, little is known about the mechanism of this activation.
In previous experiments in which the role of a pertussis toxin-sensitive trimeric G-protein in agonist-stimulated bivalent cation inflow was investigated, the cation monitored was Ca2+ (Hughes et al., 1987; Butta et al., 1993; Berven et al., 1994) . So far, no evidence for the requirement for a pertussis toxinsensitive trimeric G-protein in agonist-stimulated Mn2+ inflow inflow, the abilities of vasopressin, angiotensin II, thapsigargin and DBHQ to induce the release of Ca2' from intracellular stores, and the maximum value of [Ca2+] , reached following agonist-induced release of Ca2+ from intracellular stores. It is concluded that store-operated Ca2+ inflow in hepatocytes employs a slowly ADP-ribosylated trimeric GTP-binding protein and is the physiological mechanism, or one of the physiological mechanisms, by which vasopressin and angiotensin stimulate plasma membrane Ca2+ inflow in this cell type.
has been reported. Moreover, Kass et al. (1990) have reported that the treatment of hepatocytes with pertussis toxin for up to 4.5 h did not inhibit vasopressin-stimulated Mn2+ inflow.
The aims of the present experiments were, first, to determine whether agonist-stimulated Mn2+ inflow is blocked by pertussis toxin and, secondly, to determine whether bivalent cation inflow stimulated by thapsigargin and DBHQ requires a pertussis toxinsensitive trimeric G-protein. The results indicate that a pertussis toxin-sensitive trimeric G-protein is required for store-operated Ca2+ inflow initiated by these agents. Moreover, the results provide further evidence that store-operated Ca2l inflow is part of the physiological mechanism of action of vasopressin, angiotensin II and some other agonists in increasing the intracellular free Ca2+ concentration ([Ca2+]1) in hepatocytes. EXPERIMENTAL Materials Thapsigargin, DBHQ and pertussis toxin were obtained from Sigma-Aldrich (Castle Hill, N.S.W., Australia). All other chemicals were of the highest grade commerically available and were obtained from the sources described previously (Fernando and Barritt, 1994; Berven et al., 1994) . Stock solutions of thapsigargin and DBHQ were prepared in dimethyl sulphoxide. The final concentration of this solvent in the cell incubation medium was less than 0.5 %0 (v/v) .
Measurement of Ca2+ inflow and release of Ca2+ from intracellular stores The isolation and incubation of hepatocytes, loading of hepatocytes with Quin 2 and the measurement of agonist-stimulated Ca2+ inflow in hepatocytes loaded with Quin 2 were performed as described previously (Crofts and Barritt, 1989; Fernando and Barritt, 1994 Rates of Mn2+ and Ca2+ inflow and amounts of Ca2+ released from intracellular stores were measured as described in the Experimental section. The values are the means + S.E.M. for the number of experiments indicated in parentheses, conducted with three different cell preparations. For untreated cells, the degrees of significance for a comparison of rates of Mn2+ or Ca2+ inflow in the presence of agonist with the corresponding rate in the absence of agonist are *P < 0.01; and **P < 0.001. The degrees of significance for a comparison of rates of bivalent cation inflow for untreated cells with the corresponding rate for pertussis toxin-treated cells incubated in the presence of vasopressin, angiotensin 11 and EGF are P S 0.001, P < 0.01 and P < 0.00001 respectively, for Mn2+ inflow, and P < 0.05, P < 0.001 and P < 0.005 respectively for Ca2+ inflow. 41±+2 (5) 48 ± 6 (6) 38 + 6 (5) 38+2 (6) 38 ± 6 (5) 8 + 2 (6) (1982) as described previously (Crofts and Barritt, 1989; Fernando and Barritt, 1994 Rates of agonist-induced Ca2+ release from intracellular stores were determined using the same procedure as that employed for estimation of rates of Ca2+ inflow.
Measurement of Mn2+ inflow
Rates of Mn2+ inflow were estimated from the rate of quenching of the fluorescence of intracellular Quin 2 by Mn2+ (Hallam and Rink, 1985) as described previously (Crofts and Barritt, 1990; Fernando and Barritt, 1994 
RESULTS
In hepatocytes isolated from rats treated with pertussis toxin for 24 h, the ability of vasopressin, angiotensin II and EGF to stimulate Mn2+ inflow was completely inhibited when compared with the effects of these agonists on untreated hepatocytes (Table  1) . Pertussis toxin had no effect on the rate of Mn2+ inflow in the absence of agonist (basal Mn2+ inflow) ( Table 1 ). The toxin also blocked the stimulation of Ca2+ inflow by each agonist without altering the basal rate of Ca2+ inflow (Table 1) . Treatment with pertussis toxin did not substantially affect the ability of vasopressin and angiotensin II to induce the release of Ca2+ from intracellular stores but, as shown by others (Johnson et al., 1986; Yang et al., 1991; Garrison, 1991, 1992; Berven et al., 1994) , did inhibit the release of Ca2+ induced by EGF ( DBHQ-stimulated Mn2+ inflow was substantially inhibited in pertussis toxin-treated hepatocytes (Table 2) . Pertussis toxin did not inhibit the basal rate of Mn2+ inflow (Figures Id, cf. lb, and Table 2 ). The degree of inhibition by pertussis toxin of thapsigargin-and DBHQ-stimulated Mn2+ inflow was similar to The treatment of rats with pertussis toxin, the loading of hepatocytes with Quin 2, and the measurement of fluorescence were conducted as described in the Experimental section. Addition of thapsigargin (100 nm), Mn2+ (100 ,uM) and Gd3+ (20 IuM) Rates of Mn2+ and Ca2+ inflow, and amounts of Ca2+ released from intracellular stores were estimated as described in the Experimental section. The values are the means + S.E.M. for the number of experiments shown in parentheses conducted using between two and seven different cell preparations. The degrees of significance for a comparison of rates of Mn2+ or Ca2+ inflow obtained in the presence of an agonist with the rate observed in the absence of agonist are *P < 0.05; **P < 0.01; and ***P < 0.00001. The degrees of significance for a comparison of untreated with pertussis toxin-treated cells incubated in the presence of vasopressin, 20 nM thapsigargin, 100 nM thapsigargin or 25 ,uM DBHQ are P < 0.001, P < 0.00001, P < 0.000001 and P < 0.01 respectively, for Mn2+ inflow and P< 0.00001 and P< 0.0001 for Ca2+ inflow in the presence of vasopressin and 100 nM thapsigargin respectively. Rates of Mn2+ inflow were measured in the absence and presence of 20 ,uM Gd3+ as described in the Experimental section and in Figure 2 . The values are the means + S.E.M. for the number of experiments shown in parentheses conducted using between three and nine different cell preparations. (Fernando and Barritt, 1994) . In untreated hepatocytes, Gd3+ inhibited the rate of quenching by Mn2+ of the fluorescence of intracellular Quin 2 in the presence of thapsigargin or vasopressin by 23 % and 24% respectively ( Figure 2a and Table 3 ), whereas the inhibition by Gd3+ observed in hepatocytes treated with pertussis toxin was 6 % and 5 % for thapsigargin and vasopressin respectively ( Figure 2b and Table 3 ). Gd3+ did not inhibit basal rates of Mn2+ inflow in untreated or in pertussis toxin-treated -m hepatocytes (Table 3) .
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Treatment with pertussis toxin also caused substantial inhibition of thapsigargin-stimulated Ca2`inflow (Figure 3b , cf. Figure 3a and Table 2 ). As shown in Figure   3 ) although in the case of thapsigargin this parameter was more difficult to measure as there was some variation in the time elapsed between addition of thapsigargin and the increase in (Hughes et al., 1987; Butta et al., 1993) . Therefore it is concluded that the inhibition of agonist-stimulated bivalent cation inflow is a specific action of pertussis toxin and is unlikely to be the result of general damage to the hepatocytes induced by the toxin.
Thapsigargin and DBHQ artificially initiate the process of store-operated Ca2+ inflow, whereas it is proposed that the physiological initiator of this process is InsP3 (reviewed by Putney, 1990) . Thus it may be concluded from the present observations that store-operated bivalent cation inflow initiated by InsP3 also requires a pertussis toxin-sensitive protein. Moreover, since bivalent cation inflow stimulated by vasopressin or angiotensin II has been shown to require a pertussis toxinsensitive protein (Hughes et al., 1987; Butta et al., 1993; Berven et al., 1994; present results), the idea that store-operated bivalent cation inflow is the physiological mechanism by which these agonists stimulate Ca2+inflow is consistent with the present data. (The possibility that store-operated Ca2+ inflow shares a common pertussis toxin-sensitive step with agonist-stimulated inflow, but is not part of the physiological mechanism of action of agonists, is considered unlikely.)
In hepatocytes, the major known targets for ADP-ribosylation by pertussis toxin are the trimeric G-proteins Gi2 and G13 (Bushfield et al., 1990; Pobiner et al., 1991 The results reported here differ from those obtained by these workers in two ways. These authors did not observe stimulation of Mn2+ inflow by either thapsigargin or DBHQ (Llopis et al., 1992) nor an inhibition by pertussis toxin of vasopressin-induced Mn2+ inflow (Kass et al., 1990) . The difference in the observed effects of agonists, thapsigargin and DBHQ on Mn2+ inflow may be due to differences in the methods employed to measure Mn2+ present in the cytoplasmic space of hepatocytes. The present results were obtained using hepatocytes loaded with the acetoxy methyl ester of Quin 2 Barritt, 1989, 1990) because in this laboratory it had not been possible to find conditions for the successful loading of Fura 2 to the cytoplasmic space of hepatocytes in suspension using the acetoxy methyl ester of Fura 2 (J. N. Crofts and G. J. Barritt, unpublished work). Moreover, Glennon et al. (1992) have provided evidence which indicates that results obtained for the measurement of Mn2+ inflow in hepatocytes loaded with the acetoxy methyl ester of Fura 2 may reflect the fact that, under these conditions, Fura 2 is partly located in intracellular organelles. They found that when the introduction of Fura 2 to intracellular organelles was minimized by the microinjection of Fura 2 free acid into hepatocytes, a stimulation of Mn2+ inflow by thapsigargin was observed.
With respect to the effect ofpertussis toxin, differences between the results reported by Kass et al. (1990) and the present results may reflect differences in the time of exposure of the hepatocytes to the toxin (24 h in the present experiments compared with 4.5 h in the experiments of Kass et al.) . It has been shown, using cultured cells, that about 10 h is required to fully ADP-ribosylate pertussis toxin-sensitive trimeric G-proteins in hepatocytes (Yang et al., 1993) [cf. (Lynch et al., 1986 ) and the slow ADPribosylation of trimeric G-proteins also observed in some other cell types (Neylon et al., 1992; Blitzer et al., 1993) ].
There are some similarities between hepatocytes, in which it appears that a pertussis toxin-sensitive trimeric G-protein is required for store-operated bivalent cation inflow, and the mechanism of agonist-stimulated Ca2+ inflow in some other cell types which have also been shown to involve a pertussis toxinsensitive trimeric G-protein (Komori et al., 1992; Krautwurst et al., 1992; Gollasch et al., 1993) . Moreover, Jaconi et al. (1993) have interpreted the results of their recent experiments with granulocytes in terms of the requirement for a trimeric G-protein in the process of store-operated Ca2+ inflow. Evidence that a lowmolecular-mass (monomeric) G-protein is required for store-operated bivalent cation inflow in mast cells (Fasolato et al., 1993) and lacrimal acinar cells (Bird and Putney, 1993) has recently been reported. Since, to our knowledge, there are no reports which indicate that monomeric G-proteins are ADPribosylated, it is unlikely that the target of pertussis toxin detected in the present studies is a monomeric G-protein.
However, the present experiments do not exclude the possibility that both a trimeric and a monomeric G-protein are required in the process of store-operated Ca2+ inflow in hepatocytes.
